Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value ($000): $258,936 (100.0% shares, 0.0% debt)

Holdings (14)

— ARIAD PHARMACEUTICALS INC 26.8%

Value ($000) $69,390 Shares 12,850,000 Est. Cost $6.73 Unrealized —

DGX QUEST DIAGNOSTICS INC 18.2%

Value ($000) $47,027 Shares 775,000 Est. Cost $46.05 Unrealized +6.6%

— BIO-REFERENCE LABS INC 13.9%

Value ($000) $35,944 Shares 1,280,984 Est. Cost $27.20 Unrealized —

A AGILENT TECHNOLOGIES INC. 10.1%

Value ($000) $26,211 Shares 460,000 Est. Cost $37.20 Unrealized 0.0%

MRK MERCK & CO INC NEW 9.2%

Value ($000) $23,712 Shares 400,000 Est. Cost $31.29 Unrealized +25.8%

AMGN AMGEN INC 6.5%

Value ($000) $16,855 Shares 120,000 Est. Cost $90.34 Unrealized +4.6%

— REPROS THERAPEUTICS INC 4.3%

Value ($000) $11,210 Shares 1,132,367 Est. Cost $16.90 Unrealized —

— VIVUS INC 3.8%

Value ($000) $9,935 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— INTRA CELLULAR THERAPIES INC 1.9%

Value ($000) $4,936 Shares 360,000 Est. Cost $16.06 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 1.6%

Value ($000) $4,155 Shares 105,000 Est. Cost $37.28 Unrealized +6.9%

— KINDRED BIOSCIENCES INC 1.4%

Value ($000) $3,608 Shares 390,000 Est. Cost $14.71 Unrealized —

— AVEO PHARMACEUTICALS INC 1.1%

Value ($000) $2,854 Shares 2,570,759 Est. Cost $1.84 Unrealized —

— TARGACEPT INC 0.6%

Value ($000) $1,594 Shares 630,000 Est. Cost $4.63 Unrealized —

— ONCONOVA THERAPEUTICS INC 0.6%

Value ($000) $1,505 Shares 350,000 Est. Cost $6.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$69,390	26.8%	$6.73	—	COM	04033A100
DGX	QUEST DIAGNOSTICS INC	775,000	$47,027	18.2%	$46.05	+6.6%	COM	74834L100
—	BIO-REFERENCE LABS INC	1,280,984	$35,944	13.9%	$27.20	—	COM $.01 NEW	09057G602
A	AGILENT TECHNOLOGIES INC.	460,000	$26,211	10.1%	$37.20	0.0%	COM	00846U101
MRK	MERCK & CO INC NEW	400,000	$23,712	9.2%	$31.29	+25.8%	COM	58933Y105
AMGN	AMGEN INC	120,000	$16,855	6.5%	$90.34	+4.6%	COM	031162100
—	REPROS THERAPEUTICS INC	1,132,367	$11,210	4.3%	$16.90	—	COM NEW	76028H209
—	VIVUS INC	2,573,943	$9,935	3.8%	$9.08	—	COM	928551100
—	INTRA CELLULAR THERAPIES INC	360,000	$4,936	1.9%	$16.06	—	COM	46116X101
ENTA	ENANTA PHARMACEUTICALS INC	105,000	$4,155	1.6%	$37.28	+6.9%	COM	29251M106
—	KINDRED BIOSCIENCES INC	390,000	$3,608	1.4%	$14.71	—	COM	494577109
—	AVEO PHARMACEUTICALS INC	2,570,759	$2,854	1.1%	$1.84	—	COM	053588109
—	TARGACEPT INC	630,000	$1,594	0.6%	$4.63	—	COM	87611R306
—	ONCONOVA THERAPEUTICS INC	350,000	$1,505	0.6%	$6.34	—	COM	68232V108